Bond Screener
IQVIA Inc.
LEI 549300PLWY28YB00C717
Organization name
IQVIA Inc.
Country name
USA
Country of registration
USA
Industry
Professional Services
Credit Ratings
in foreign currency
Public debt
7,315 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
IQVIA Inc. develops, produces, and retails pharmaceutical products. The Company offers medicines for cardiovascular, diabetes, endocrinology, infestious diseases, oncology, pediatrics, and vaccines. Quintiles Transnational markets its products worldwide.
|
General information
-
Organization nameIQVIA Inc.
-
Organization statusOperating organization
-
Address83 Wooster Heights Road Danbury, USA, 06810
-
Site
News
-
New issue: Issuer IQVIA Inc. issued international bonds (USU46093AH05) with the coupon rate of 6.25% in the amount of USD 1250 mln maturing in 202916/11/2023
-
New issues: Issuer IQVIA Inc. released international bonds (USU46093AF49, USU46093AG22) in the amount of USD 750, USD 500 mln maturing in 2028, 2030 respectively.19/05/2023
-
Upcoming issue: IQVIA Inc.17/02/2021
Affiliates
Stocks
Bond classification
- Organization does not disclose IFRS/US GAAP financial statements
General information
-
Organization nameIQVIA Inc.
-
Organization statusOperating organization
-
Address83 Wooster Heights Road Danbury, USA, 06810
-
Site
Codes
-
LEI549300PLWY28YB00C717
-
SIC8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
-
NACE*** ***
-
NAICS*** ***
